Status | Study |
Recruiting |
Study Name: Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis Condition: Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Date: 2015-03-10 Interventions: Other: Brain MRI |
Active, not recruiting |
Study Name: A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo Condition: Primary Progressive Multiple Sclerosis Date: 2014-10-31 Interventions: Drug: Laquinimod Laquinimod 0. |
Active, not recruiting |
Study Name: Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS Condition: Primary Progressive Multiple Sclerosis Multiple Sclerosis, Secondary Progressive Date: 2014-10-03 Interventions: Drug: Andrographolides 140 mg |
Recruiting |
Study Name: A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients Condition: Primary Progressive Multiple Sclerosis Secondary Progressive Multiple Sclerosis Date: 2014-09-29 Interventions: Drug: Rituximab Other Name: Rituxan |
Recruiting |
Study Name: Measuring Active Microglia in Progressive Multiple Sclerosis Condition: Secondary Progressive Multiple Sclerosis Date: 2014-07-30 Interventions: Radiation: [C11]PK-1195 PET scan PET scan with tracer [C11]PK-1195 |
Active, not recruiting |
Study Name: A Double Blind, Randomized, Placebo Controlled, Crossover Study of the Effectiveness of Oral Fampridine in Improving Upper Limb Function in Progressive Multiple Sclerosis Condition: Secondary Progressive Multiple Sclerosis Primary Progressive Multiple Sclerosis Date: 2014-05-19 Interventions: Drug: Fampridine Drug: Placebo |
Completed |
Study Name: Tear Analysis in the Diagnosis of Multiple Sclerosis Condition: Primary Progressive Multiple Sclerosis Date: 2013-11-22 Interventions: Procedure: tears sampling |
Active, not recruiting |
Study Name: Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Condition: Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Date: 2013-10-29 Interventions: Drug: ibudilast Other Name: MN |
Completed |
Study Name: China Betaferon Adherence, Coping and Nurse Support Study Condition: Multiple Sclerosis, Chronic Progressive Date: 2011-09-19 Interventions: Drug: Interferon beta-1b (Betaseron, BAY86-5046) All patients will be prescribed with Betaseron and be i |
Completed |
Study Name: Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis Condition: Secondary Progressive Multiple Sclerosis Primary Progressive Multiple Sclerosis Date: 2010-08-30 Interventions: Biological: MIS416 MIS416 intravenously every week |